Scientists create heat-resistant compounds for pharmaceuticals

Scientists from Perm State Technical University in Russia have developed a method that allows the use of biologically active "Calcon" compounds in drug manufacturing, despite their sensitivity to heat treatment. These compounds are considered a preferred option due to their low toxicity and cost, but the challenge has been their inability to withstand traditional thermal manufacturing processes. This new solution opens up broader possibilities for the pharmaceutical industry to benefit from the advantages of "Calcon," which could help reduce costs and enhance the safety of pharmaceutical products.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل